Skip to the main content.
Contact Us

At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

Ion Channels Applications

Ion Channel Drug Discovery, Research and Screening

Illustration of a nerve cell on a colored background with light effects-1

Ion channel dysfunction is attributed to multiple diseases and disorders including autoimmune diseasessleeping disordersAlzheimer disease, cystic fibrosistrigeminal neuralgia, and various cancers.

E-protein present in the SARS-COV1 and SARS-COV2 also forms an ion channel [McClenaghan et al., 2020]

Check the application pages to see how IonFlux can accelerate your ion channel research.

From neurons to cancer cells, ion channels represent the second largest target for existing drugs [Overington et al., 2006] surpassed only by g-protein. With the advent of more advanced screening systems for compounds acting on ion channels, these proteins are becoming auspicious targets for the development of novel therapeutic agents

IonFlux Mercury

Automated Patch Clamp

Learn more about Fluxion's next-generation APC, IonFlux Mercury!

IonFlux Mercury System

Resources Library

Visit the Resources Library for webinars, application notes and publications

Resources Library